Non-viral infections and antimicrobial resistance in the time of COVID-19: what to expect?

Boyanova, Lyudmila; Markovska, Rumyana; Mitov, Ivan; Gergova, Raina

Boyanova, Lyudmila; Markovska, Rumyana; Mitov, Ivan; Gergova, Raina.

Boyanova L; Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.
Markovska R; Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.
Mitov I; Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.
Gergova R; Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.

Expert Rev Clin Pharmacol ; 15(8): 907-909, 2022 08.

Article in English | MEDLINE | ID: covidwho-1972962

Subject(s)

COVID-19; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Drug Resistance, Bacterial; Humans; SARS-CoV-2

Keywords

Antibiotics; COVID-19; antifungals; bacterial infections; coinfections; fungal infections; resistance

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Expert Rev Clin Pharmacol Year: 2022 Document Type: Article Affiliation country: 17512433.2022.2108403

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google